A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
Residential medication management reviews have proven to be beneficial in identifying medicine-related problems, so why are they so under-utilised?
A head for business and a desire to improve medicine safety inspired PSA Life Member Rob Richards to develop a digital opioid substitution therapy system that helps pharmacists and patients.
After years of little movement in downscheduling of medicines in Australia, 2021 will usher in a flurry of activity – but Appendix M remains conspicuously empty.
In a world of information overload, how can pharmacists prevent patients from falling into a medicine-induced downward spiral?
Every day Australians swallow millions of pills without much awareness of adverse effects or drug interactions.
Problems with medicines are ‘alarmingly common’,...
With medicine shortages continuing to be an issue for the foreseeable future, pharmacists share how they are managing patients’ conditions and expectations.
A proposal to support residential aged care facilities to directly engage pharmacists is among the strategic measures put forward by PSA in its 2021–22 Federal Budget Submission.
After 119 years, the indispensable pharmacists’ reference guide has evolved to match practice with its second digital as well as 25th print edition.
The 2021 Australia Day Honours List included several high profile pharmacists and educators in the profession.
Three pharmacists share what they love about the profession and what they hope 2021 holds.
A new initiative to transform how pharmacists label antibiotics has been praised by the Federal Department of Health.
